MATERIALS:
Program Agenda
Panelist Biographies
View the full set of materials
SESSIONS:
Annuals & Perennials: The 2021 Ethics Potpourri for Corporate Counsel
Presenters:
Nadia Martyn, Vice President, Deputy General Counsel & Privacy Officer, Delta Dental of Minnesota
Sarah Stroebel, Senior Vice President & Deputy General Counsel, U.S. Bank National Association
Kenneth Jorgensen, Dorsey & Whitney LLP
For lawyers, even the “old” ethics issues never really get old. In the context of 2021—with remote and hybrid workplaces front and center—this panel will tackle the slate of ethics issues that have arisen or resurfaced most recently: the ethics of long-term remote practice juxtaposed against unauthorized practice and lawyer licensing requirements; non-compete clauses in lawyer employment contracts; business transactions with corporate client employers; and attorney-client privilege in various scenarios, including internal investigations, sale or insolvency, common interest in Minnesota, and advice to affiliates and foreign affiliates.
Tensions, Trade and Tariffs: Globalization Revisited
Presenters:
Anne Murphy, Director, International Business Relations | Government Relations, Cargill, Incorporated
Jennifer Okerlund, Director Counsel | International Trade, Target Corporation
Christopher Bercaw, Nelson Dong and Kate Francis, Dorsey & Whitney LLP
The interconnectedness of our world has become all the more apparent in the last 18 months. Across the globe, the United States is deeply reliant on the smooth transport of goods, ideas, people, and services in order to support our day-to-day lives and business operations—and, as we see time and time again, when international relations are not so smooth, the ripple effects are widespread. This experienced panel will explore recent global developments challenging legal and business leaders (as well as individual consumers) around the world:
- Trump era Section 301 tariffs and counter-tariffs in Europe and China
- The UK post-Brexit, the European Union and prospects for a US-UK Free Trade Agreement
- Trade sanctions, export controls and values-based trade: Cuba, China
- Evolving US and UK foreign direct investment restrictions
Directors Under Pressure: So, What Else is New?
Presenters:
Peter Carter, Executive Vice President, Chief Legal Officer and Corporate Secretary, Delta Air Lines, Inc.
James Chosy, Senior Executive Vice President and General Counsel, U.S. Bancorp
Dannette Smith, Secretary to the Board of Directors and Senior Deputy General Counsel, UnitedHealth Group Incorporated
Robert Rosenbaum and Cam Hoang, Dorsey & Whitney LLP
Advising boards of directors has never been more complex or high-stakes. Assisting directors in understanding and addressing issues of significance to investors and other interested parties is critical in today’s fast-changing environment. This panel of experienced and savvy boardroom veterans will help you guide your boards through some of the most pressing issues of the day, including: Environmental, Social, and Governance (ESG) matters; Diversity, Equity, and Inclusion (DE&I) initiatives; cybersecurity; and pandemic protocols.
Presenters:
Hon. Toddrick Barnette, Chief Judge, Hennepin County District Court, Minnesota, Fourth Judicial District
Laura Hammargren, Assistant General Counsel, Litigation, 3M Company
Beth Forsythe and Andrea Wechter, Dorsey & Whitney LLP
2020 upended seemingly everything, including the way trial and investigations lawyers do their jobs and how judges run courtrooms and manage dockets. 2021 has seen a return to something resembling “normal,” but what will be COVID-19’s lasting impacts on our work? Which activities need to take place in person, and which can (and perhaps should) happen virtually? What COVID-related claims, from employment to fraud, will we continue to see for years to come? How have in-house litigation managers changed and improved processes for hiring and oversight of outside counsel? This panel brings together perspectives from the judiciary, corporate counsel and law firm litigation practitioners to share insights on COVID’s lasting impacts on trials and investigations.